This Analyst Sees Recovery For PolyPid Despite Failed Phase 3 Readout
Raymond James downgraded PolyPid Ltd (NASDAQ:PYPD) from Strong Buy to Outperform post SHIELD I Phase 3 results that, despite consistency and evidence of…
This High-Yielding Dividend REIT Is Downgraded, As 2 Year Treasury Yield Outpaces Average Corporate Dividend Yield
As the U.S. 2-Year Treasury Yield has remained inversely related to the U.S. 10-Year Treasury Yield for some time now, this has signaled concerns for many investors and economists, as historically this points to a recession ahead.
Dawson James Downgrades Arcimoto to Sell
Dawson James analyst James McIlree downgrades Arcimoto (NASDAQ:FUV) from Neutral to Sell.
William Blair Downgrades Signify Health to Market Perform
William Blair analyst Matt Larew downgrades Signify Health (NYSE:SGFY) from Outperform to Market Perform.
JP Morgan Downgrades Carlyle Secured Lending to Neutral, Announces $14.5 Price Target
JP Morgan analyst Melissa Wedel downgrades Carlyle Secured Lending (NASDAQ:CGBD) from Overweight to Neutral and announces $14.5 price target.
JP Morgan Downgrades Rocket Companies to Neutral, Lowers Price Target to $8.5
JP Morgan analyst Richard Shane downgrades Rocket Companies (NYSE:RKT) from Overweight to Neutral and lowers the price target from $11 to $8.5.
Morgan Stanley Downgrades Edison to Underweight, Announces $62 Price Target
Morgan Stanley analyst David Arcaro downgrades Edison (NYSE:EIX) from Equal-Weight to Underweight and announces $62 price target.
Goldman Sachs Downgrades StoneCo to Sell, Lowers Price Target to $7.8
Goldman Sachs analyst Tito Labarta downgrades StoneCo (NASDAQ:STNE) from Neutral to Sell and lowers the price target from $9.8 to $7.8.
Wells Fargo Downgrades Greif to Equal-Weight, Announces $71 Price Target
Wells Fargo analyst Gabe Hajde downgrades Greif (NYSE:GEF) from Overweight to Equal-Weight and announces $71 price target.
Citigroup Downgrades FedEx to Neutral, Lowers Price Target to $225
Citigroup analyst Christian Wetherbee downgrades FedEx (NYSE:FDX) from Buy to Neutral and lowers the price target from $270 to $225.